Thyroid Carcinoma
Also known as: Carcinoma thyroid / Thyroid carcinoma NOS / Thyroid cancer / Malignant neoplasm of thyroid gland / Thyroid neoplasms malignant / Thyroid neoplasm malignant / Thyroid gland cancer / Malignant tumor of thyroid gland (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09293 | Iodide I-131 | A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine. |
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 1 | Enrolling by Invitation | 1 |
DB05153 | Cabozantinib | 1 | Completed | 1 |
DB08875 | Cabozantinib | 1 | Completed | 1 |
DB12483 | Copanlisib | 1 | Completed | 1 |
DB05382 | Iodine | 1 | Recruiting | 1 |
DB08881 | Vemurafenib | 1 | Completed | 1 |
DB09293 | Iodide I-131 | 2 | Recruiting | 1 |
DB06603 | Panobinostat | 2 | Completed | 1 |
DB06589 | Pazopanib | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB15685 | Selpercatinib | 2 | Recruiting | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB14892 | Spartalizumab | 2 | Recruiting | 1 |
DB01268 | Sunitinib | 2 | Completed | 1 |
DB15106 | Surufatinib | 2 | Completed | 1 |
DB00024 | Thyrotropin alfa | 2 | Recruiting | 1 |
DB14922 | Tislelizumab | 2 | Recruiting | 1 |
DB16604 | Fibrin | 3 | Completed | 1 |
DB09078 | Lenvatinib | 4 | Not Yet Recruiting | 1 |
DB09074 | Olaparib | 4 | Not Yet Recruiting | 1 |
DB09073 | Palbociclib | 4 | Not Yet Recruiting | 1 |
DB06589 | Pazopanib | 4 | Not Yet Recruiting | 1 |
DB01268 | Sunitinib | 4 | Not Yet Recruiting | 1 |
DB00398 | Sorafenib | Not Available | Active Not Recruiting | 1 |
DB00024 | Thyrotropin alfa | Not Available | Active Not Recruiting | 1 |
DB05238 | Vemurafenib | Not Available | Active Not Recruiting | 1 |
DB08881 | Vemurafenib | Not Available | Active Not Recruiting | 1 |